首页 > 最新文献

Integrative Medicine Research最新文献

英文 中文
Effects of Asparagus officinalis for burning mouth syndrome: A systematic review of randomized controlled trials 芦笋治疗灼口综合征的疗效:随机对照试验的系统综述
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-10 DOI: 10.1016/j.imr.2025.101223
Chen Shen , Xue-Feng Wang , Xiao-Ti Wu , Xin-Xin Liu , Nicola Robinson , Jian-Ping Liu

Background

Burning mouth syndrome (BMS) lacks optimal treatments. This systematic review assessed Asparagus officinalis, a natural product with anti-inflammatory/antioxidant properties, for managing this chronic pain disorder.

Methods

PubMed, the Cochrane Library, EMBASE, Web of Science, Scopus, and four Chinese databases were searched until February, 2025 for randomized controlled trials (RCTs) involving adults with BMS. Asparagus officinalis products alone or in combination with conventional medications were included. Outcomes included pain, symptoms, psychological outcomes and salivary function. The GRADE approach was used to assess evidence certainty.

Results

Six RCTs with 336 participants were included. Compared to vitamin B complex alone, Asparagus officinalis capsules alone significantly improved the pain-intensity-based effective rate (RR 6.00, 95 % CI [1.61, 22.34]). Compared to conventional medicines, Asparagus officinalis capsules with conventional medicines significantly increased subjective pain scores (MD 1.51, 95 % CI [1.19, 1.83]), symptom-based effective rate (RR 1.27, 95 % CI [1.14, 1.42]), daily water intake score (MD 1.32, 95 % CI [1.00, 1.64]), sleep duration score (MD 1.88, 95 % CI [1.61, 2.15]), and decreased anxiety and depression scores, while Asparagus officinalis oral liquid combined with mecobalamin significantly reduced 10-point VAS (MD -1.40, 95 % CI [-2.19, -0.61]) and increased the unstimulated salivary flow rate (USFR).The certainty of evidence was all graded as low.

Conclusions

Asparagus officinalis products may improve pain intensity, symptoms, psychological outcomes, and salivary function in patients with BMS. However, the low certainty of evidence due to study limitations and small sample sizes suggests the need for well-designed, large-scale real-world studies to confirm these findings and establish their clinical applicability.

Protocol registration

PROSPERO (CRD420250651920).
灼口综合征(BMS)缺乏最佳治疗方法。本系统综述评估了芦笋,一种具有抗炎/抗氧化特性的天然产品,用于治疗这种慢性疼痛疾病。方法检索spubmed、Cochrane Library、EMBASE、Web of Science、Scopus和4个中文数据库,截至2025年2月,检索涉及成年BMS患者的随机对照试验(RCTs)。芦笋产品单独使用或与常规药物联合使用。结果包括疼痛、症状、心理结果和唾液功能。GRADE方法用于评估证据的确定性。结果共纳入6项随机对照试验,共336名受试者。与单独使用维生素B复合物相比,芦笋胶囊可显著提高基于疼痛强度的有效率(RR 6.00, 95% CI[1.61, 22.34])。与常规药物相比,芦竹胶囊联合常规药物显著提高主观疼痛评分(MD 1.51, 95% CI[1.19, 1.83])、症状有效率(RR 1.27, 95% CI[1.14, 1.42])、每日饮水量评分(MD 1.32, 95% CI[1.00, 1.64])、睡眠时间评分(MD 1.88, 95% CI[1.61, 2.15]),降低焦虑和抑郁评分。芦笋口服液联合甲钴胺可显著降低10点VAS (MD -1.40, 95% CI[-2.19, -0.61]),提高非刺激唾液流率(USFR)。证据的确定性都被评为低。结论芦笋制品可改善BMS患者的疼痛强度、症状、心理结局和唾液功能。然而,由于研究的局限性和小样本量,证据的低确定性表明需要精心设计的大规模现实世界研究来证实这些发现并建立其临床适用性。协议注册prospero (CRD420250651920)。
{"title":"Effects of Asparagus officinalis for burning mouth syndrome: A systematic review of randomized controlled trials","authors":"Chen Shen ,&nbsp;Xue-Feng Wang ,&nbsp;Xiao-Ti Wu ,&nbsp;Xin-Xin Liu ,&nbsp;Nicola Robinson ,&nbsp;Jian-Ping Liu","doi":"10.1016/j.imr.2025.101223","DOIUrl":"10.1016/j.imr.2025.101223","url":null,"abstract":"<div><h3>Background</h3><div>Burning mouth syndrome (BMS) lacks optimal treatments. This systematic review assessed <em>Asparagus officinalis</em>, a natural product with anti-inflammatory/antioxidant properties, for managing this chronic pain disorder.</div></div><div><h3>Methods</h3><div>PubMed, the Cochrane Library, EMBASE, Web of Science, Scopus, and four Chinese databases were searched until February, 2025 for randomized controlled trials (RCTs) involving adults with BMS. <em>Asparagus officinalis</em> products alone or in combination with conventional medications were included. Outcomes included pain, symptoms, psychological outcomes and salivary function. The GRADE approach was used to assess evidence certainty.</div></div><div><h3>Results</h3><div>Six RCTs with 336 participants were included. Compared to vitamin B complex alone, <em>Asparagus officinalis</em> capsules alone significantly improved the pain-intensity-based effective rate (RR 6.00, 95 % CI [1.61, 22.34]). Compared to conventional medicines, <em>Asparagus officinalis</em> capsules with conventional medicines significantly increased subjective pain scores (MD 1.51, 95 % CI [1.19, 1.83]), symptom-based effective rate (RR 1.27, 95 % CI [1.14, 1.42]), daily water intake score (MD 1.32, 95 % CI [1.00, 1.64]), sleep duration score (MD 1.88, 95 % CI [1.61, 2.15]), and decreased anxiety and depression scores, while <em>Asparagus officinalis</em> oral liquid combined with mecobalamin significantly reduced 10-point VAS (MD -1.40, 95 % CI [-2.19, -0.61]) and increased the unstimulated salivary flow rate (USFR).The certainty of evidence was all graded as low.</div></div><div><h3>Conclusions</h3><div><em>Asparagus officinalis</em> products may improve pain intensity, symptoms, psychological outcomes, and salivary function in patients with BMS. However, the low certainty of evidence due to study limitations and small sample sizes suggests the need for well-designed, large-scale real-world studies to confirm these findings and establish their clinical applicability.</div></div><div><h3>Protocol registration</h3><div>PROSPERO (CRD420250651920).</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"15 1","pages":"Article 101223"},"PeriodicalIF":3.0,"publicationDate":"2025-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144926315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prompt engineering for generative artificial intelligence chatbots in health research: A practical guide for traditional, complementary, and integrative medicine researchers 健康研究中生成式人工智能聊天机器人的快速工程:传统、补充和综合医学研究人员的实用指南
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-09 DOI: 10.1016/j.imr.2025.101222
Jeremy Y. Ng
Generative artificial intelligence (GenAI) chatbots powered by large language models (LLMs) are increasingly used in health research to support a range of academic and clinical activities. While increasingly adopted in biomedical research, their application in traditional, complementary, and integrative medicine (TCIM) remains underexplored. TCIM presents unique challenges, including complex interventions, culturally embedded practices, and variable terminology. This article provides a practical, evidence-informed guide to help TCIM researchers engage responsibly with GenAI chatbots through prompt engineering, the design of clear, structured, and purposeful prompts to improve output relevance and accuracy. The guide outlines strategies to tailor GenAI chatbot interactions to the methodological and epistemological diversity of TCIM. It presents use cases across the research process, including research question development, study design, literature searches, selection of reporting guidelines and appraisal tools, quantitative and qualitative analysis, writing and dissemination, and implementation planning. For each stage, the guide offers examples and best practices while emphasizing that AI-generated content should always serve as a starting point, not a final product, and must be reviewed and verified using credible sources. Potential risks such as hallucinated outputs, embedded bias, and ethical challenges are discussed, particularly in culturally sensitive contexts. Transparency in GenAI chatbot use and researcher accountability are emphasized as essential principles. While GenAI chatbots can expand access to research support and foster innovation in TCIM, they cannot substitute for critical thinking, methodological rigour, or domain-specific expertise. Used responsibly, GenAI chatbots can augment human judgment and contribute meaningfully to the evolution of TCIM scholarship.
由大型语言模型(llm)驱动的生成式人工智能(GenAI)聊天机器人越来越多地用于健康研究,以支持一系列学术和临床活动。虽然越来越多地用于生物医学研究,但它们在传统、补充和综合医学(TCIM)中的应用仍未得到充分探索。TCIM提出了独特的挑战,包括复杂的干预、文化嵌入的实践和可变的术语。本文提供了一个实用的、有证据的指南,帮助TCIM研究人员通过快速工程、设计清晰、结构化和有目的的提示来负责任地参与GenAI聊天机器人,以提高输出的相关性和准确性。该指南概述了定制GenAI聊天机器人交互的策略,以适应TCIM的方法论和认识论多样性。它展示了整个研究过程中的用例,包括研究问题开发、研究设计、文献检索、报告指南和评估工具的选择、定量和定性分析、写作和传播以及实施计划。对于每个阶段,指南都提供了示例和最佳实践,同时强调人工智能生成的内容应始终作为起点,而不是最终产品,并且必须使用可靠的来源进行审查和验证。潜在的风险,如幻觉输出,嵌入式偏见和伦理挑战进行了讨论,特别是在文化敏感的背景下。GenAI聊天机器人使用的透明度和研究人员的问责制被强调为基本原则。虽然GenAI聊天机器人可以扩大获得研究支持的机会,并促进TCIM的创新,但它们不能取代批判性思维、方法论的严密性或特定领域的专业知识。负责任地使用GenAI聊天机器人可以增强人类的判断力,并为TCIM学术的发展做出有意义的贡献。
{"title":"Prompt engineering for generative artificial intelligence chatbots in health research: A practical guide for traditional, complementary, and integrative medicine researchers","authors":"Jeremy Y. Ng","doi":"10.1016/j.imr.2025.101222","DOIUrl":"10.1016/j.imr.2025.101222","url":null,"abstract":"<div><div>Generative artificial intelligence (GenAI) chatbots powered by large language models (LLMs) are increasingly used in health research to support a range of academic and clinical activities. While increasingly adopted in biomedical research, their application in traditional, complementary, and integrative medicine (TCIM) remains underexplored. TCIM presents unique challenges, including complex interventions, culturally embedded practices, and variable terminology. This article provides a practical, evidence-informed guide to help TCIM researchers engage responsibly with GenAI chatbots through prompt engineering, the design of clear, structured, and purposeful prompts to improve output relevance and accuracy. The guide outlines strategies to tailor GenAI chatbot interactions to the methodological and epistemological diversity of TCIM. It presents use cases across the research process, including research question development, study design, literature searches, selection of reporting guidelines and appraisal tools, quantitative and qualitative analysis, writing and dissemination, and implementation planning. For each stage, the guide offers examples and best practices while emphasizing that AI-generated content should always serve as a starting point, not a final product, and must be reviewed and verified using credible sources. Potential risks such as hallucinated outputs, embedded bias, and ethical challenges are discussed, particularly in culturally sensitive contexts. Transparency in GenAI chatbot use and researcher accountability are emphasized as essential principles. While GenAI chatbots can expand access to research support and foster innovation in TCIM, they cannot substitute for critical thinking, methodological rigour, or domain-specific expertise. Used responsibly, GenAI chatbots can augment human judgment and contribute meaningfully to the evolution of TCIM scholarship.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"14 4","pages":"Article 101222"},"PeriodicalIF":3.0,"publicationDate":"2025-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving evidence synthesis: Clarifying explanatory and effectiveness randomized clinical trials in complementary and integrative medicine 改进证据合成:阐明补充和中西医结合的解释性和有效性随机临床试验
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-08 DOI: 10.1016/j.imr.2025.101220
Susan Arentz
{"title":"Improving evidence synthesis: Clarifying explanatory and effectiveness randomized clinical trials in complementary and integrative medicine","authors":"Susan Arentz","doi":"10.1016/j.imr.2025.101220","DOIUrl":"10.1016/j.imr.2025.101220","url":null,"abstract":"","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"14 4","pages":"Article 101220"},"PeriodicalIF":3.0,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcutaneous electrical acupoint stimulation: a potential bridge linking traditional Chinese medicine and AI-driven transformation in modern healthcare 经皮穴位电刺激:连接中医与人工智能驱动的现代医疗转型的潜在桥梁
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-08 DOI: 10.1016/j.imr.2025.101221
Fan Qu , Rong Zhang
{"title":"Transcutaneous electrical acupoint stimulation: a potential bridge linking traditional Chinese medicine and AI-driven transformation in modern healthcare","authors":"Fan Qu ,&nbsp;Rong Zhang","doi":"10.1016/j.imr.2025.101221","DOIUrl":"10.1016/j.imr.2025.101221","url":null,"abstract":"","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"14 3","pages":"Article 101221"},"PeriodicalIF":3.0,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144860872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acupuncture versus cognitive behavioral therapy for anxiety among cancer survivors with insomnia: An exploratory analysis of a randomized clinical trial 针灸与认知行为疗法治疗失眠癌症幸存者的焦虑:一项随机临床试验的探索性分析
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-07 DOI: 10.1016/j.imr.2025.101213
Eunbin Kwag , Xiaotong Li , Sheila Garland , Karolina Bryl , Lauren Taylor , Qing S. Li , Lindsay Amann , Jun J. Mao , Kelly M. McConnell

Background

Anxiety and insomnia frequently co-occur among cancer survivors and are strongly interconnected, yet no widely accepted intervention simultaneously targets both symptoms.

Methods

Data were drawn from a dual-center, parallel-group, randomized, comparative effectiveness trial evaluating acupuncture versus CBT-I for insomnia. Seventy-six participants with baseline Hospital Anxiety and Depression Scale-Anxiety (HADS-A) scores of ≥8 were included. Both interventions were administered over eight weeks, with follow-up until 20 weeks. Anxiety was assessed at baseline, week 8, and week 20 using HADS-A. A linear mixed-effects model was used to examine mean change in HADS-A scores. Additionally, responder analyses were conducted, with insomnia and anxiety responders defined as patients demonstrating clinically meaningful improvements in either outcome by week 8.

Results

Both CBT-I and acupuncture significantly reduced HADS-A scores at week 8 (CBT-I: -3.75; acupuncture: -3.14) and week 20 (CBT-I: -3.05; acupuncture: -2.66) compared to baseline (all p < 0.001). There was no between-group difference (p=0.85). In responder analyses, CBT-I showed greater anxiety reduction in insomnia responders (-4.62) than non-responders (-0.45), at both time points (week 8: p=0.0046; week 20: p=0.038). In the acupuncture group, the difference in anxiety reduction between insomnia responders (-3.96) and non-responders (-1.58) was not statistically significant.

Conclusion

Both acupuncture and CBT-I effectively manage comorbid anxiety and insomnia in cancer survivors. Acupuncture may address these symptoms independently, while CBT-I may improve them in an interconnected manner.

Trial registration

ClinicalTrials.gov registration (NCT02356575).
背景:焦虑和失眠经常在癌症幸存者中同时发生,并且它们之间有着紧密的联系,但目前还没有广泛接受的干预措施同时针对这两种症状。方法数据来自一项双中心、平行组、随机、比较疗效的试验,评估针刺与CBT-I治疗失眠的疗效。76名基线医院焦虑和抑郁量表-焦虑(HADS-A)评分≥8分的参与者被纳入研究。两种干预措施均在8周内实施,随访至20周。在基线、第8周和第20周使用HADS-A评估焦虑。采用线性混合效应模型检验HADS-A评分的平均变化。此外,还进行了应答者分析,失眠和焦虑应答者定义为在第8周时任一结果均有临床意义改善的患者。结果与基线相比,CBT-I和针灸在第8周(CBT-I: -3.75;针灸:-3.14)和第20周(CBT-I: -3.05;针灸:-2.66)均显著降低了HADS-A评分(均p <; 0.001)。组间差异无统计学意义(p=0.85)。在应答者分析中,CBT-I显示,在两个时间点(第8周:p=0.0046;第20周:p=0.038),失眠应答者的焦虑减少(-4.62)比无应答者(-0.45)更大。在针灸组中,失眠反应者(-3.96)和无反应者(-1.58)之间焦虑减少的差异无统计学意义。结论针刺和CBT-I均能有效控制癌症幸存者的共病焦虑和失眠。针灸可以单独解决这些症状,而CBT-I可以通过相互关联的方式改善它们。临床试验注册(NCT02356575)。
{"title":"Acupuncture versus cognitive behavioral therapy for anxiety among cancer survivors with insomnia: An exploratory analysis of a randomized clinical trial","authors":"Eunbin Kwag ,&nbsp;Xiaotong Li ,&nbsp;Sheila Garland ,&nbsp;Karolina Bryl ,&nbsp;Lauren Taylor ,&nbsp;Qing S. Li ,&nbsp;Lindsay Amann ,&nbsp;Jun J. Mao ,&nbsp;Kelly M. McConnell","doi":"10.1016/j.imr.2025.101213","DOIUrl":"10.1016/j.imr.2025.101213","url":null,"abstract":"<div><h3>Background</h3><div>Anxiety and insomnia frequently co-occur among cancer survivors and are strongly interconnected, yet no widely accepted intervention simultaneously targets both symptoms.</div></div><div><h3>Methods</h3><div>Data were drawn from a dual-center, parallel-group, randomized, comparative effectiveness trial evaluating acupuncture versus CBT-I for insomnia. Seventy-six participants with baseline Hospital Anxiety and Depression Scale-Anxiety (HADS-A) scores of ≥8 were included. Both interventions were administered over eight weeks, with follow-up until 20 weeks. Anxiety was assessed at baseline, week 8, and week 20 using HADS-A. A linear mixed-effects model was used to examine mean change in HADS-A scores. Additionally, responder analyses were conducted, with insomnia and anxiety responders defined as patients demonstrating clinically meaningful improvements in either outcome by week 8.</div></div><div><h3>Results</h3><div>Both CBT-I and acupuncture significantly reduced HADS-A scores at week 8 (CBT-I: -3.75; acupuncture: -3.14) and week 20 (CBT-I: -3.05; acupuncture: -2.66) compared to baseline (all p &lt; 0.001). There was no between-group difference (p=0.85). In responder analyses, CBT-I showed greater anxiety reduction in insomnia responders (-4.62) than non-responders (-0.45), at both time points (week 8: <em>p</em>=0.0046; week 20: <em>p</em>=0.038). In the acupuncture group, the difference in anxiety reduction between insomnia responders (-3.96) and non-responders (-1.58) was not statistically significant.</div></div><div><h3>Conclusion</h3><div>Both acupuncture and CBT-I effectively manage comorbid anxiety and insomnia in cancer survivors. Acupuncture may address these symptoms independently, while CBT-I may improve them in an interconnected manner.</div></div><div><h3>Trial registration</h3><div>ClinicalTrials.gov registration (NCT02356575).</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"14 4","pages":"Article 101213"},"PeriodicalIF":3.0,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic effects of Gunryeong-tang on the cardio-renal axis in an animal model of pulmonary hypertension 健灵汤对肺动脉高压动物模型心肾轴的治疗作用
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-07 DOI: 10.1016/j.imr.2025.101218
Se Won Na , Hye Yoom Kim , Jung Joo Yoon , Mi Hyeon Hong , Ai Lin Tai , Yun Jeong Yang , Chae Yeon Yoo , Ho Sub Lee , Dae Gill Kang
Background: In the realm of cardiovascular and renal health, the modulation of oxidative stress and inflammation within the cardio-renal axis plays a pivotal role. This study investigates the therapeutic potential of Gunryeong-tang (GRT), a traditional Korean herbal formula combining Oryeongsan (Wulingsan) and Sagunza-tang (Sijunzi-tang), specifically in addressing cardio-renal axis dysfunction induced by pulmonary arterial hypertension (PAH-r). Methods: PAH-r models were induced through intraperitoneal injection of monocrotaline (MCT) at a daily dose of 50 mg/kg for 5 days to simulate pulmonary hypertension, a common cause of cardio-renal syndrome. The primary focus is on evaluating its anti-fibroinflammatory effects and its ability to modulate oxidative stress and inflammation. The treatment group received oral administration of GRT (100 mg/kg/day). Results: Various parameters were assessed, including right ventricular (RV) enlargement and fibrosis, lung weight, pulmonary fibrosis, expression of cardiac hypertrophy markers, and involvement of specific pathways (TGF-β/p-Smad2 and HMGB-1/TLR4/MyD88/NF-κB). Renal dysfunction markers, such as blood urea nitrogen (BUN), creatinine clearance rate (Ccr), glomerular dilatation, tubular fibrosis, and protein expression of kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL), were evaluated to highlight the formula's anti-fibroinflammatory effects. Treatment resulted in significant improvements in the PAH-r group. It alleviated RV enlargement and fibrosis, suppressed lung weight increase, and mitigated pulmonary fibrosis. The administration downregulated cardiac hypertrophy markers (CTGF, TGF-β, and α-SMA mRNA levels) and inhibited the TGF-β/p-Smad2 and HMGB-1/TLR4/MyD88/NF-κB pathways, showcasing GRT's anti-fibroinflammatory properties. Additionally, the treatment ameliorated renal dysfunction, as evidenced by reduced BUN and Ccr levels, improved glomerular dilatation, and reduced protein expression of KIM-1 and NGAL. GRT demonstrates significant therapeutic potential in managing cardio-renal axis dysfunction induced by PAH-r, emphasizing its multifaceted benefits in modulating oxidative stress and inflammation within this axis. Conclusions: This study provides valuable insights into the underlying mechanisms, highlighting the modulation of cardiac hypertrophy markers and specific pathways. These findings underscore the promising role of GRT as a viable treatment option for cardio-renal axis dysfunction associated with PAH-r.
背景:在心血管和肾脏健康领域,心肾轴氧化应激和炎症的调节起着关键作用。本研究探讨了由五灵山(武陵山)和四君子汤(四君子汤)组合而成的韩国传统中药健灵汤(GRT)对肺动脉高压(PAH-r)所致心肾轴功能障碍的治疗潜力。方法:采用日剂量50 mg/kg的MCT腹腔注射诱导PAH-r模型,连续5 d模拟肺动脉高压(心肾综合征的常见病因)。主要的重点是评估其抗纤维炎作用及其调节氧化应激和炎症的能力。治疗组给予口服GRT (100 mg/kg/d)。结果:对右心室(RV)增大和纤维化、肺重量、肺纤维化、心肌肥厚标志物的表达以及特定通路(TGF-β/p-Smad2和HMGB-1/TLR4/MyD88/NF-κB)的参与情况进行了评估。评估肾功能障碍标志物,如血尿素氮(BUN)、肌酐清除率(Ccr)、肾小球扩张、小管纤维化、肾损伤分子-1 (KIM-1)和中性粒细胞明胶酶相关脂钙蛋白(NGAL)的蛋白表达,以突出该配方的抗纤维炎作用。治疗后PAH-r组明显改善。减轻右心室增大和纤维化,抑制肺重量增加,减轻肺纤维化。下调心肌肥厚标志物(CTGF、TGF-β和α-SMA mRNA水平),抑制TGF-β/p-Smad2和HMGB-1/TLR4/MyD88/NF-κB通路,显示GRT的抗纤维炎症特性。此外,治疗改善肾功能,如降低BUN和Ccr水平,改善肾小球扩张,降低KIM-1和NGAL蛋白表达。GRT在治疗PAH-r诱导的心肾轴功能障碍方面显示出显著的治疗潜力,强调其在调节该轴的氧化应激和炎症方面的多方面益处。结论:这项研究为潜在的机制提供了有价值的见解,突出了心脏肥厚标志物和特定途径的调节。这些发现强调了GRT作为与PAH-r相关的心肾轴功能障碍的可行治疗选择的有希望的作用。
{"title":"Therapeutic effects of Gunryeong-tang on the cardio-renal axis in an animal model of pulmonary hypertension","authors":"Se Won Na ,&nbsp;Hye Yoom Kim ,&nbsp;Jung Joo Yoon ,&nbsp;Mi Hyeon Hong ,&nbsp;Ai Lin Tai ,&nbsp;Yun Jeong Yang ,&nbsp;Chae Yeon Yoo ,&nbsp;Ho Sub Lee ,&nbsp;Dae Gill Kang","doi":"10.1016/j.imr.2025.101218","DOIUrl":"10.1016/j.imr.2025.101218","url":null,"abstract":"<div><div><em>Background:</em> In the realm of cardiovascular and renal health, the modulation of oxidative stress and inflammation within the cardio-renal axis plays a pivotal role. This study investigates the therapeutic potential of Gunryeong-tang (GRT), a traditional Korean herbal formula combining Oryeongsan (Wulingsan) and Sagunza-tang (Sijunzi-tang), specifically in addressing cardio-renal axis dysfunction induced by pulmonary arterial hypertension (PAH-r). <em>Methods:</em> PAH-r models were induced through intraperitoneal injection of monocrotaline (MCT) at a daily dose of 50 mg/kg for 5 days to simulate pulmonary hypertension, a common cause of cardio-renal syndrome. The primary focus is on evaluating its anti-fibroinflammatory effects and its ability to modulate oxidative stress and inflammation. The treatment group received oral administration of GRT (100 mg/kg/day). <em>Results</em>: Various parameters were assessed, including right ventricular (RV) enlargement and fibrosis, lung weight, pulmonary fibrosis, expression of cardiac hypertrophy markers, and involvement of specific pathways (TGF-β/p-Smad2 and HMGB-1/TLR4/MyD88/NF-κB). Renal dysfunction markers, such as blood urea nitrogen (BUN), creatinine clearance rate (Ccr), glomerular dilatation, tubular fibrosis, and protein expression of kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL), were evaluated to highlight the formula's anti-fibroinflammatory effects. Treatment resulted in significant improvements in the PAH-r group. It alleviated RV enlargement and fibrosis, suppressed lung weight increase, and mitigated pulmonary fibrosis. The administration downregulated cardiac hypertrophy markers (CTGF, TGF-β, and α-SMA mRNA levels) and inhibited the TGF-β/p-Smad2 and HMGB-1/TLR4/MyD88/NF-κB pathways, showcasing GRT's anti-fibroinflammatory properties. Additionally, the treatment ameliorated renal dysfunction, as evidenced by reduced BUN and Ccr levels, improved glomerular dilatation, and reduced protein expression of KIM-1 and NGAL. GRT demonstrates significant therapeutic potential in managing cardio-renal axis dysfunction induced by PAH-r, emphasizing its multifaceted benefits in modulating oxidative stress and inflammation within this axis. <em>Conclusions</em>: This study provides valuable insights into the underlying mechanisms, highlighting the modulation of cardiac hypertrophy markers and specific pathways. These findings underscore the promising role of GRT as a viable treatment option for cardio-renal axis dysfunction associated with PAH-r.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"14 4","pages":"Article 101218"},"PeriodicalIF":3.0,"publicationDate":"2025-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144886927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A national survey on the integration of traditional Chinese medicine and artificial intelligence: attitudes and perceptions from the individuals with health needs 一项关于中医与人工智能结合的全国调查:来自健康需求个体的态度和看法
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-06 DOI: 10.1016/j.imr.2025.101219
Xinyin Hu , Yinger Gu , Hye Won Lee , Xiaoteng Chen , Ying Li , Xinyue Li , Qiaoping Zhao , Wei Wang , Haifeng Huang , Lisi Wang , Nv Xia , Wenjie Wu , Lingling Lou , Pingchun Yang , Ke Ren , Jinglu Guo , Cheng Wang , Longlong Fan , Zheng Yao , Guomei You , Fan Qu

Background

Traditional Chinese medicine (TCM) plays an indispensable role in the healthcare system. Artificial intelligence (AI) opens a new pathway for TCM modernization, while also addressing critical healthcare challenges. The present national survey was conducted to assess the attitudes and perceptions of individuals with health needs regarding the integration of TCM with AI.

Methods

A cross-sectional national survey was conducted at 13 medical institutions across China. A structured, self-reported questionnaire was administered to 2587 individuals with health needs, including patients seeking TCM/Western medical treatment and individuals undergoing routine physical examinations, between June 27th and July 11th, 2025.

Results

A total of 1641 (63.4 %) respondents were familiar with the TCM-AI equipment, and 61.7 % respondents were willing to try TCM diagnosis and treatment services combined with AI. 43.5 % respondents trusted the diagnosis results provided by the TCM-AI equipment. In the subgroup analysis, respondents aged 18–34, with a bachelor's degree or associate's degree as their educational background, and working as employees of state organs, showed greater acceptance and trust towards the integration of TCM and AI (P < 0.005). The top three most promising applications were the intelligent syndrome differentiation system (46.9 %), TCM four diagnostic instruments (39.9 %), and intelligent TCM formula (39.0 %).

Conclusion

The integration of TCM and AI demonstrates promising acceptance among health-seeking individuals in China, with younger and educated populations who have health demands for TCM showing particularly high trust, and intelligent syndrome differentiation systems highlight a clear pathway for AI to modernize TCM practice by augmenting diagnostic accuracy and treatment personalization.
背景中药在医疗保健系统中扮演着不可或缺的角色。人工智能(AI)为中医药现代化开辟了一条新途径,同时也解决了关键的医疗挑战。本全国性调查旨在评估有健康需求的个人对中医与人工智能结合的态度和看法。方法对全国13家医疗机构进行横断面调查。本研究于2025年6月27日至7月11日对2587名有健康需求的患者(包括寻求中西医治疗的患者和进行常规体检的患者)进行结构化、自我报告式问卷调查。结果有1641名受访者(63.4%)熟悉中医-人工智能设备,61.7%的受访者愿意尝试中医与人工智能结合的诊疗服务。43.5%的受访者相信中医-人工智能设备提供的诊断结果。在亚组分析中,18-34岁、本科或大专学历、国家机关工作人员的受访者对中医与人工智能结合的接受度和信任度更高(P < 0.005)。最具应用前景的前三位分别是智能辨证系统(46.9%)、中医四诊仪(39.9%)和智能中药方剂(39.0%)。结论中医与人工智能的融合在中国的求医人群中显示出良好的接受度,对中医有健康需求的年轻、受过教育的人群表现出特别高的信任度,智能辨证系统为人工智能通过提高诊断准确性和治疗个性化来实现中医实践的现代化提供了明确的途径。
{"title":"A national survey on the integration of traditional Chinese medicine and artificial intelligence: attitudes and perceptions from the individuals with health needs","authors":"Xinyin Hu ,&nbsp;Yinger Gu ,&nbsp;Hye Won Lee ,&nbsp;Xiaoteng Chen ,&nbsp;Ying Li ,&nbsp;Xinyue Li ,&nbsp;Qiaoping Zhao ,&nbsp;Wei Wang ,&nbsp;Haifeng Huang ,&nbsp;Lisi Wang ,&nbsp;Nv Xia ,&nbsp;Wenjie Wu ,&nbsp;Lingling Lou ,&nbsp;Pingchun Yang ,&nbsp;Ke Ren ,&nbsp;Jinglu Guo ,&nbsp;Cheng Wang ,&nbsp;Longlong Fan ,&nbsp;Zheng Yao ,&nbsp;Guomei You ,&nbsp;Fan Qu","doi":"10.1016/j.imr.2025.101219","DOIUrl":"10.1016/j.imr.2025.101219","url":null,"abstract":"<div><h3>Background</h3><div>Traditional Chinese medicine (TCM) plays an indispensable role in the healthcare system. Artificial intelligence (AI) opens a new pathway for TCM modernization, while also addressing critical healthcare challenges. The present national survey was conducted to assess the attitudes and perceptions of individuals with health needs regarding the integration of TCM with AI.</div></div><div><h3>Methods</h3><div>A cross-sectional national survey was conducted at 13 medical institutions across China. A structured, self-reported questionnaire was administered to 2587 individuals with health needs, including patients seeking TCM/Western medical treatment and individuals undergoing routine physical examinations, between June 27th and July 11th, 2025.</div></div><div><h3>Results</h3><div>A total of 1641 (63.4 %) respondents were familiar with the TCM-AI equipment, and 61.7 % respondents were willing to try TCM diagnosis and treatment services combined with AI. 43.5 % respondents trusted the diagnosis results provided by the TCM-AI equipment. In the subgroup analysis, respondents aged 18–34, with a bachelor's degree or associate's degree as their educational background, and working as employees of state organs, showed greater acceptance and trust towards the integration of TCM and AI (<em>P</em> &lt; 0.005). The top three most promising applications were the intelligent syndrome differentiation system (46.9 %), TCM four diagnostic instruments (39.9 %), and intelligent TCM formula (39.0 %).</div></div><div><h3>Conclusion</h3><div>The integration of TCM and AI demonstrates promising acceptance among health-seeking individuals in China, with younger and educated populations who have health demands for TCM showing particularly high trust, and intelligent syndrome differentiation systems highlight a clear pathway for AI to modernize TCM practice by augmenting diagnostic accuracy and treatment personalization.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"14 4","pages":"Article 101219"},"PeriodicalIF":3.0,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use and perception of generative artificial intelligence in traditional Korean medicine education: A cross-sectional survey of undergraduate students in Korea 生成式人工智能在韩国传统医学教育中的使用和感知:对韩国本科生的横断面调查
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-06 DOI: 10.1016/j.imr.2025.101216
Seungwon Shin , Jihyun Sang , Ji-sun You

Background

This study aimed to examine the usage, awareness, and satisfaction related to generative AI (GenAI) among undergraduate students at a Traditional Korean Medicine (TKM) college in Korea and to identify factors associated with GenAI use and satisfaction.

Methods

A structured questionnaire consisting of 56 items across six domains was administered, covering demographics, general and TKM-specific GenAI use, satisfaction, educational experiences, and future expectations. Descriptive statistics, univariable analysis, multivariable logistic regression, and correlation analysis were performed.

Results

A total of 234 students across six academic years participated in the survey. Most respondents were aware of GenAI (88.5 %) and used it for general purposes (79.9 %). However, only 16.2 % actively used it for TKM learning. While 70.4 % were satisfied with using GenAI in general, only 45.8 % felt satisfied with its use for TKM education. Factors significantly associated with GenAI use or satisfaction included enrollment in the TKM curriculum, older age, prior major, scholarship receipt, and self-directed GenAI learning. Although only 18.8 % had experienced GenAI in formal TKM courses, 96.2 % viewed GenAI as necessary in TKM education.

Conclusion

A notable gap exists between students’ interest and the limited integration of GenAI in TKM curricula. To close this gap, GenAI should be systematically incorporated into educational programs, accompanied by faculty training and institutional support to enhance students’ digital readiness and learning outcomes.
本研究旨在调查韩国一所传统韩国医学(TKM)学院本科生对生成式人工智能(GenAI)的使用、认知和满意度,并确定与GenAI使用和满意度相关的因素。方法采用6个领域的56项结构化问卷,涵盖人口统计、通用和tkm特定的GenAI使用、满意度、教育经历和未来期望。进行描述性统计、单变量分析、多变量logistic回归及相关分析。结果共有234名学生在6个学年参与了调查。大多数应答者(88.5%)知道GenAI,并将其用于一般用途(79.9%)。然而,只有16.2%的人积极地将其用于TKM学习。70.4%的人对GenAI的总体使用感到满意,而只有45.8%的人对其在TKM教育中的使用感到满意。与GenAI使用或满意度显著相关的因素包括TKM课程的注册、年龄、先前的专业、奖学金接收和自主GenAI学习。虽然只有18.8%的人在正式的TKM课程中经历过GenAI,但96.2%的人认为GenAI在TKM教育中是必要的。结论学生的兴趣与GenAI在TKM课程中的有限整合存在显著差距。为了缩小这一差距,应将GenAI系统地纳入教育计划,并辅以教师培训和机构支持,以提高学生的数字化准备和学习成果。
{"title":"Use and perception of generative artificial intelligence in traditional Korean medicine education: A cross-sectional survey of undergraduate students in Korea","authors":"Seungwon Shin ,&nbsp;Jihyun Sang ,&nbsp;Ji-sun You","doi":"10.1016/j.imr.2025.101216","DOIUrl":"10.1016/j.imr.2025.101216","url":null,"abstract":"<div><h3>Background</h3><div>This study aimed to examine the usage, awareness, and satisfaction related to generative AI (GenAI) among undergraduate students at a Traditional Korean Medicine (TKM) college in Korea and to identify factors associated with GenAI use and satisfaction.</div></div><div><h3>Methods</h3><div>A structured questionnaire consisting of 56 items across six domains was administered, covering demographics, general and TKM-specific GenAI use, satisfaction, educational experiences, and future expectations. Descriptive statistics, univariable analysis, multivariable logistic regression, and correlation analysis were performed.</div></div><div><h3>Results</h3><div>A total of 234 students across six academic years participated in the survey. Most respondents were aware of GenAI (88.5 %) and used it for general purposes (79.9 %). However, only 16.2 % actively used it for TKM learning. While 70.4 % were satisfied with using GenAI in general, only 45.8 % felt satisfied with its use for TKM education. Factors significantly associated with GenAI use or satisfaction included enrollment in the TKM curriculum, older age, prior major, scholarship receipt, and self-directed GenAI learning. Although only 18.8 % had experienced GenAI in formal TKM courses, 96.2 % viewed GenAI as necessary in TKM education.</div></div><div><h3>Conclusion</h3><div>A notable gap exists between students’ interest and the limited integration of GenAI in TKM curricula. To close this gap, GenAI should be systematically incorporated into educational programs, accompanied by faculty training and institutional support to enhance students’ digital readiness and learning outcomes.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"14 4","pages":"Article 101216"},"PeriodicalIF":3.0,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using artificial intelligence for the development of a living evidence map: The pharmacopuncture example 使用人工智能开发活证据图:药物穿刺的例子
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-06 DOI: 10.1016/j.imr.2025.101217
Chan-Young Kwon

Background

Evidence map is a tool that visualizes the research status to identify research gaps and set priorities, but it has the limitation of the burden of continuous literature monitoring. Pharmacopuncture is a therapeutic modality used in Korean medicine that involves the injection of medicinal extracts into acupoints. This study aimed to develop an artificial intelligence (AI)-based automated system for building and maintaining a living evidence map in the field of pharmacopuncture research and verify its performance.

Methods

A web-based system that automates literature search, selection, data extraction, and classification using PubMed API and Gemini AI was developed. The accuracy of nine tasks was evaluated and time efficiency was measured using manual review by experts as a standard reference. A visualization system using interactive bubble charts was implemented to provide a research gap identification function.

Results

The AI system achieved an overall accuracy of 94.00% (error rate of 6.00%) for 202 articles, including detailed data extraction for 90 articles. Task-specific performance varied from sample size extraction (0% error rate) to pharmacopuncture name extraction (22.22% error rate), with high accuracy of over 90% in most tasks. Time efficiency was improved by 68.9% (190 vs. 59 minutes, including quality control), demonstrating that daily updates are practically feasible.

Conclusions

The developed visualization system significantly improves the existing static evidence organization method by intuitively identifying research gaps. The AI-based living evidence map enables continuous evidence monitoring in the field of pharmacopuncture research with high accuracy and significant time savings.
证据图谱是一种可视化研究现状、识别研究差距和确定研究重点的工具,但它存在文献持续监测负担的局限性。药物穿刺是韩国医学中使用的一种治疗方法,将药物提取物注射到穴位上。本研究旨在开发一个基于人工智能(AI)的自动化系统,用于构建和维护药物穿刺研究领域的活证据地图,并验证其性能。方法利用PubMed API和Gemini AI开发基于web的文献自动检索、选择、数据提取和分类系统。以专家手工评审为标准参照,对9项任务的准确性进行了评价,并对时间效率进行了衡量。利用交互式气泡图实现了一个可视化系统,以提供研究差距识别功能。结果人工智能系统对202篇文章的总体准确率为94.00%(错误率为6.00%),其中90篇文章的详细数据提取。从样本量提取(错误率为0%)到药物穿刺名称提取(错误率为22.22%),在大多数任务中准确率都在90%以上。时间效率提高了68.9%(190分钟vs 59分钟,包括质量控制),表明每日更新实际上是可行的。结论所开发的可视化系统通过直观地识别研究空白,显著改进了现有的静态证据组织方法。基于人工智能的活体证据地图能够在药物穿刺研究领域实现持续的证据监测,具有高精度和显著的时间节省。
{"title":"Using artificial intelligence for the development of a living evidence map: The pharmacopuncture example","authors":"Chan-Young Kwon","doi":"10.1016/j.imr.2025.101217","DOIUrl":"10.1016/j.imr.2025.101217","url":null,"abstract":"<div><h3>Background</h3><div>Evidence map is a tool that visualizes the research status to identify research gaps and set priorities, but it has the limitation of the burden of continuous literature monitoring. Pharmacopuncture is a therapeutic modality used in Korean medicine that involves the injection of medicinal extracts into acupoints. This study aimed to develop an artificial intelligence (AI)-based automated system for building and maintaining a living evidence map in the field of pharmacopuncture research and verify its performance.</div></div><div><h3>Methods</h3><div>A web-based system that automates literature search, selection, data extraction, and classification using PubMed API and Gemini AI was developed. The accuracy of nine tasks was evaluated and time efficiency was measured using manual review by experts as a standard reference. A visualization system using interactive bubble charts was implemented to provide a research gap identification function.</div></div><div><h3>Results</h3><div>The AI system achieved an overall accuracy of 94.00% (error rate of 6.00%) for 202 articles, including detailed data extraction for 90 articles. Task-specific performance varied from sample size extraction (0% error rate) to pharmacopuncture name extraction (22.22% error rate), with high accuracy of over 90% in most tasks. Time efficiency was improved by 68.9% (190 vs. 59 minutes, including quality control), demonstrating that daily updates are practically feasible.</div></div><div><h3>Conclusions</h3><div>The developed visualization system significantly improves the existing static evidence organization method by intuitively identifying research gaps. The AI-based living evidence map enables continuous evidence monitoring in the field of pharmacopuncture research with high accuracy and significant time savings.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"14 4","pages":"Article 101217"},"PeriodicalIF":3.0,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A national survey on how to improve the integration of traditional Chinese medicine and artificial intelligence: Attitudes and perceptions from medical staff 一项关于如何提高中医与人工智能结合的全国性调查:医务人员的态度和看法
IF 3 4区 医学 Q2 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-08-05 DOI: 10.1016/j.imr.2025.101214
Yinger Gu , Xinyin Hu , Hye Won Lee , Zheng Yao , Tianyi Zhou , Nv Xia , Pingchun Yang , Jinglu Guo , Haifeng Huang , Lisi Wang , Wei Wang , Cheng Wang , Qiaoping Zhao , Lingling Lou , Wenjie Wu , Ke Ren , Guomei You , Longlong Fan , Jue Zhou , Fangfang Wang , Fan Qu

Background

With the significant development of artificial intelligence (AI) in recent years, the inheritance and innovation of traditional Chinese medicine (TCM) urgently require the help of AI technology. The present study was to evaluate the attitudes and perceptions of medical staff towards the integration of TCM and AI development.

Methods

A cross-sectional national survey was conducted at 13 medical institutions across China. A structured and self-reported questionnaire, consisting of six sections with a total of 14 items, was administered to 1100 medical staff between June 27th and July 11th, 2025.

Results

In the process of clinical practice, 62.1 % of medical staff were willing to try TCM diagnosis and treatment services combined with AI. The top three important processes of integration of TCM and AI were medical research, personalized generation of regimen, and intelligent inquiry. The top three concerns about the potential risks associated with the integration of TCM and AI were the misinterpretation of cultural contexts, flexibility in dialectical treatment, and simplification of traditional TCM experience by algorithms. The top three most promising applications were the intelligent syndrome differentiation system (54.6 %), the TCM four diagnostic instruments (49.1 %), and the acupuncture and Tui Na robot (47.8 %). The top three most important factors in the application of AI in TCM were accuracy (78.0 %), convenience of operation (67.5 %), and participation of medical staff (60.9 %).

Conclusion

The integration of TCM and AI has a brilliant and promising future, prioritizing diagnostic accuracy while addressing cultural/clinical adaptation challenges in key applications, such as syndrome differentiation systems.
随着近年来人工智能(AI)的显著发展,中医药的传承与创新迫切需要AI技术的帮助。本研究旨在评估医务人员对中医与人工智能结合发展的态度和看法。方法对全国13家医疗机构进行横断面调查。本文于2025年6月27日至7月11日对1100名医务人员进行问卷调查,问卷分为6个部分,共14个项目。结果在临床实践过程中,62.1%的医护人员愿意尝试人工智能结合中医诊疗服务。中医与人工智能融合的前三大重要过程是医学研究、个性化方案生成和智能问诊。中医与人工智能结合的三大潜在风险是对文化背景的误解、辨证治疗的灵活性以及算法对传统中医经验的简化。最具应用前景的前三名分别是智能辨证系统(54.6%)、中医四诊仪(49.1%)和针灸推拿机器人(47.8%)。人工智能在中医中应用的前三个最重要的因素是准确性(78.0%)、操作便利性(67.5%)和医务人员的参与(60.9%)。结论中医与人工智能的融合具有光明的前景,可以优先考虑诊断准确性,同时解决关键应用(如辨证系统)的文化/临床适应性挑战。
{"title":"A national survey on how to improve the integration of traditional Chinese medicine and artificial intelligence: Attitudes and perceptions from medical staff","authors":"Yinger Gu ,&nbsp;Xinyin Hu ,&nbsp;Hye Won Lee ,&nbsp;Zheng Yao ,&nbsp;Tianyi Zhou ,&nbsp;Nv Xia ,&nbsp;Pingchun Yang ,&nbsp;Jinglu Guo ,&nbsp;Haifeng Huang ,&nbsp;Lisi Wang ,&nbsp;Wei Wang ,&nbsp;Cheng Wang ,&nbsp;Qiaoping Zhao ,&nbsp;Lingling Lou ,&nbsp;Wenjie Wu ,&nbsp;Ke Ren ,&nbsp;Guomei You ,&nbsp;Longlong Fan ,&nbsp;Jue Zhou ,&nbsp;Fangfang Wang ,&nbsp;Fan Qu","doi":"10.1016/j.imr.2025.101214","DOIUrl":"10.1016/j.imr.2025.101214","url":null,"abstract":"<div><h3>Background</h3><div>With the significant development of artificial intelligence (AI) in recent years, the inheritance and innovation of traditional Chinese medicine (TCM) urgently require the help of AI technology. The present study was to evaluate the attitudes and perceptions of medical staff towards the integration of TCM and AI development.</div></div><div><h3>Methods</h3><div>A cross-sectional national survey was conducted at 13 medical institutions across China. A structured and self-reported questionnaire, consisting of six sections with a total of 14 items, was administered to 1100 medical staff between June 27th and July 11th, 2025.</div></div><div><h3>Results</h3><div>In the process of clinical practice, 62.1 % of medical staff were willing to try TCM diagnosis and treatment services combined with AI. The top three important processes of integration of TCM and AI were medical research, personalized generation of regimen, and intelligent inquiry. The top three concerns about the potential risks associated with the integration of TCM and AI were the misinterpretation of cultural contexts, flexibility in dialectical treatment, and simplification of traditional TCM experience by algorithms. The top three most promising applications were the intelligent syndrome differentiation system (54.6 %), the TCM four diagnostic instruments (49.1 %), and the acupuncture and Tui Na robot (47.8 %). The top three most important factors in the application of AI in TCM were accuracy (78.0 %), convenience of operation (67.5 %), and participation of medical staff (60.9 %).</div></div><div><h3>Conclusion</h3><div>The integration of TCM and AI has a brilliant and promising future, prioritizing diagnostic accuracy while addressing cultural/clinical adaptation challenges in key applications, such as syndrome differentiation systems.</div></div>","PeriodicalId":13644,"journal":{"name":"Integrative Medicine Research","volume":"14 4","pages":"Article 101214"},"PeriodicalIF":3.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144866393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Integrative Medicine Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1